LNCAROD

Across TCGA pan-cancer cohorts, LNCAROD RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LNCAROD data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LNCAROD RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LNCAROD expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

BRCA, LUAD, and MESO are the cancer types where LNCAROD RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	All	0.872	0.931	<.001	101	view →
LUAD	OS	Quartile	All	0.555	0.709	<.001	85	view →
MESO	DFS	Tertile	All	0.248	0.461	.001	76	view →
UCEC	OS	Tertile	All	0.890	0.938	.008	72	view →
KIRP	OS	Quartile	IV	0.111	0.519	.004	58	view →
PAAD	OS	Quartile	All	0.187	0.556	<.001	52	view →
KICH	OS	Tertile	All	0.876	1.000	.001	42	view →
BLCA	OS	Tertile	II,III,IV	0.641	0.767	.003	41	view →
STAD	OS	Median	IV	0.156	0.511	.001	40	view →
UVM	OS	Tertile	All	0.273	0.707	.005	36	view →
HNSC	DFS	Quartile	All	0.650	0.797	<.001	36	view →
SKCM	DFS	Tertile	IV	0.772	0.226	.013	29	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LNCAROD–BRCA (DFS)

Open the BRCA breakdown →